Literature DB >> 21814858

CRT or CRT-D devices? The case for 'high energy' devices.

Leslie A Saxon1, Bruce L Wilkoff.   

Abstract

The decision to implant a CRT or CRT-D device is an important one that requires a careful look at the patient and discussion with the patient as to the benefits and risks associated with each approach. The good news is that CRT provided in any device is a robust therapy that improves many measures of heart failure outcome in very high-risk patients. We argue that in most circumstances, it is much easier to turn a tachycardia device off than not to have the benefit of prompt defibrillation should a tachycardia event occur. While cost is always a consideration, the responsibility of the physician is to individualize patient care and advocate for each patient, based upon the best available therapies.

Entities:  

Mesh:

Year:  2012        PMID: 21814858     DOI: 10.1007/s10741-011-9276-9

Source DB:  PubMed          Journal:  Heart Fail Rev        ISSN: 1382-4147            Impact factor:   4.214


  15 in total

1.  Cardiac resynchronization in chronic heart failure.

Authors:  William T Abraham; Westby G Fisher; Andrew L Smith; David B Delurgio; Angel R Leon; Evan Loh; Dusan Z Kocovic; Milton Packer; Alfredo L Clavell; David L Hayes; Myrvin Ellestad; Robin J Trupp; Jackie Underwood; Faith Pickering; Cindy Truex; Peggy McAtee; John Messenger
Journal:  N Engl J Med       Date:  2002-06-13       Impact factor: 91.245

2.  Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure.

Authors:  Michael R Bristow; Leslie A Saxon; John Boehmer; Steven Krueger; David A Kass; Teresa De Marco; Peter Carson; Lorenzo DiCarlo; David DeMets; Bill G White; Dale W DeVries; Arthur M Feldman
Journal:  N Engl J Med       Date:  2004-05-20       Impact factor: 91.245

3.  More is better with cardiac resynchronization therapy--but is it enough?

Authors:  Leslie Anne Saxon
Journal:  Eur Heart J       Date:  2006-07-07       Impact factor: 29.983

Review 4.  Selecting patients for discussion of the ICD as primary prevention for sudden death in heart failure.

Authors:  Lynne Warner Stevenson; Akshay S Desai
Journal:  J Card Fail       Date:  2006-08       Impact factor: 5.712

Review 5.  ACC/AHA/HRS 2008 guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: executive summary.

Authors:  Andrew E Epstein; John P Dimarco; Kenneth A Ellenbogen; N A Mark Estes; Roger A Freedman; Leonard S Gettes; A Marc Gillinov; Gabriel Gregoratos; Stephen C Hammill; David L Hayes; Mark A Hlatky; L Kristin Newby; Richard L Page; Mark H Schoenfeld; Michael J Silka; Lynne Warner Stevenson; Michael O Sweeney
Journal:  Heart Rhythm       Date:  2008-05-19       Impact factor: 6.343

6.  Mode of death in advanced heart failure: the Comparison of Medical, Pacing, and Defibrillation Therapies in Heart Failure (COMPANION) trial.

Authors:  Peter Carson; Inder Anand; Christopher O'Connor; Brian Jaski; Jonathan Steinberg; Amy Lwin; JoAnn Lindenfeld; Jalal Ghali; Jalil Ghali; Jodi H Barnet; Arthur M Feldman; Michael R Bristow
Journal:  J Am Coll Cardiol       Date:  2005-12-20       Impact factor: 24.094

7.  Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.

Authors:  Arthur J Moss; Wojciech Zareba; W Jackson Hall; Helmut Klein; David J Wilber; David S Cannom; James P Daubert; Steven L Higgins; Mary W Brown; Mark L Andrews
Journal:  N Engl J Med       Date:  2002-03-19       Impact factor: 91.245

8.  Predictors of sudden cardiac death and appropriate shock in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Trial.

Authors:  Leslie A Saxon; Michael R Bristow; John Boehmer; Steven Krueger; David A Kass; Teresa De Marco; Peter Carson; Lorenzo DiCarlo; Arthur M Feldman; Elizabeth Galle; Fred Ecklund
Journal:  Circulation       Date:  2006-12-11       Impact factor: 29.690

9.  The effect of cardiac resynchronization on morbidity and mortality in heart failure.

Authors:  John G F Cleland; Jean-Claude Daubert; Erland Erdmann; Nick Freemantle; Daniel Gras; Lukas Kappenberger; Luigi Tavazzi
Journal:  N Engl J Med       Date:  2005-03-07       Impact factor: 91.245

10.  Myocardial gene expression in heart failure patients treated with cardiac resynchronization therapy responders versus nonresponders.

Authors:  Marc Vanderheyden; Wilfried Mullens; Leen Delrue; Marc Goethals; Bernard de Bruyne; William Wijns; Peter Geelen; Sofie Verstreken; Francis Wellens; Jozef Bartunek
Journal:  J Am Coll Cardiol       Date:  2008-01-15       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.